CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- Open-market buys, last 90 days
- $5,000,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,000,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | Whelan, Jr. Robert M. Director | Conversion | +59,524 | 84,524 | ||
| 2020-01-31 | Whelan, Jr. Robert M. Director | Conversion | +11,176 | $4.80 | $54K | 95,700 |
| 2020-01-31 | Whelan, Jr. Robert M. Director | Conversion · Series A-1 Preferred Stock | −83,333 | 0 | ||
| 2020-01-31 | Whelan, Jr. Robert M. Director | Conversion · Convertible Note | −11,176 | $4.80 | $54K | 0 |
| 2020-01-31 | Bruck Claudine Director | Purchase | +800 | $6.00 | $5K | 800 |
| 2020-01-31 | Bruck Claudine Director | Conversion | +3,969 | 4,769 | ||
| 2020-01-31 | Bruck Claudine Director | Conversion | +1,117 | $4.80 | $5K | 5,886 |
| 2020-01-31 | Bruck Claudine Director | Conversion · Series A-1 Preferred Stock | −5,556 | 0 | ||
| 2020-01-31 | Bruck Claudine Director | Conversion · Convertible Note | −1,117 | $4.80 | $5K | 0 |
| 2020-01-31 | Maccecchini Maria-Luisa President and CEO | Purchase | +1,600 | $6.00 | $10K | 207,942 |
| 2020-01-31 | Maccecchini Maria-Luisa President and CEO | Conversion | +7,937 | 215,879 | ||
| 2020-01-31 | Maccecchini Maria-Luisa President and CEO | Conversion | +762,896 | 978,775 | ||
| 2020-01-31 | Maccecchini Maria-Luisa President and CEO | Conversion · Series A-1 Preferred Stock | −11,111 | 0 | ||
| 2020-01-31 | Maccecchini Maria-Luisa President and CEO | Conversion · Series A Preferred Stock | −1,068,054 | 0 | ||
| 2020-01-31 | McGroarty Jeffrey Brian Chief Financial Officer | Purchase | +33,333 | $6.00 | $200K | 33,333 |
| 2020-01-31 | White Mark K. Director | Purchase | +1,734 | $6.00 | $10K | 1,734 |
| 2020-01-31 | White Mark K. Director | Conversion | +11,548 | 13,282 | ||
| 2020-01-31 | White Mark K. Director | Conversion | +34,643 | 47,925 | ||
| 2020-01-31 | White Mark K. Director | Conversion | +3,252 | $4.80 | $16K | 51,177 |
| 2020-01-31 | White Mark K. Director | Conversion · Series A-1 Preferred Stock | −16,167 | 0 |
Page 7 of 8 · 142 trades